跳至主要内容
临床试验/NCT07269002
NCT07269002已完成不适用

"Role of Clinical Pharmacy and Mobile Medical Applications in Detection and Minimization of Different Medication Errors in Hospitalized Patients From Adults and Children".

Beni-Suef University1 个研究点 分布在 1 个国家目标入组 3,600 人开始时间: 2025年3月15日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
3,600
试验地点
1
主要终点
Medication-Safety Composite Indicator

研究概览

简要总结

This study evaluated a pharmacist-led medication-safety program in hospitalized patients. The program included routine inpatient medication review and the use of smartphone-based clinical decision-support applications to identify potential medication issues and support therapeutic decision-making. The study was conducted in both adult and pediatric inpatients as part of routine clinical care. No investigational drugs or devices were used.

详细描述

This study was conducted to assess the impact of a structured pharmacist-led medication-safety program implemented across inpatient units in a multispecialty hospital. The program incorporated routine clinical pharmacist review of inpatient medication therapy and the use of smartphone-based clinical decision-support applications to assist with identifying potential medication issues and supporting therapeutic optimization.

The intervention was applied prospectively in both adult and pediatric inpatients receiving pharmacologic treatment. All activities were performed as part of routine clinical service enhancement, without the use of investigational drugs or devices. The study focused on evaluating medication-safety indicators, clinical process measures, and patient-related outcomes before and after implementation of the pharmacist-led program.

The aim of the project was to enhance medication accuracy, reduce preventable medication-related problems, and support evidence-based decision-making in a real-world hospital environment. This description summarizes the overall service-improvement approach without disclosing study-specific operational details.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized patients receiving medication therapy
  • Adult and pediatric inpatients
  • Patients receiving at least one scheduled medication dose during admission

排除标准

  • Patients not receiving any pharmacologic treatment
  • Patients admitted for procedures with no medication administration
  • Patients discharged before assessment could be performed

结局指标

主要结局

Medication-Safety Composite Indicator

时间窗: From hospital admission through study completion (an average of 5 days)

A composite measure assessing medication-safety performance in inpatient settings, including identification of medication discrepancies, potential medication risks, and pharmacist-detected issues during routine clinical care. The measure reflects overall improvement in medication-safety processes following the implementation of the pharmacist-led program.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Mohammed Abd Elhamid Mohammed Tony

Clinical Pharmacist and Principal Investigator

Beni-Suef University

研究点 (1)

Loading locations...

相似试验

Clinical Pharmacist Impact Study | 临床试验